Liontrust Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DOCU
DocuSign
DOCU
|
+$170M |
| 2 |
PayPal
PYPL
|
+$157M |
| 3 |
Illumina
ILMN
|
+$75.8M |
| 4 |
Visa
V
|
+$57.4M |
| 5 |
NVR
NVR
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$41.2M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$34.2M |
| 3 |
Cadence Design Systems
CDNS
|
+$22.6M |
| 4 |
Moderna
MRNA
|
+$19.2M |
| 5 |
Brookfield Infrastructure
BIPC
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.22% |
| 2 | Healthcare | 16.94% |
| 3 | Financials | 16.38% |
| 4 | Communication Services | 10.81% |
| 5 | Consumer Discretionary | 7.38% |
Similar funds
Liontrust Investment Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Liontrust Investment Partners held 246 positions worth $8.41B, up 16% from $7.23B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Liontrust Investment Partners deployed $856M of net new capital in Q4 2021, opening 22 new positions and adding to 89 existing holdings. Its largest new stake was Morgan Stanley: 140,000 shares worth $13.7M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Intuit, an estimated $41.2M trimmed.
- Liontrust Investment Partners's largest Q4 2021 buy was Morgan Stanley: 140,000 shares worth $13.7M.
- Liontrust Investment Partners added most to DocuSign in Q4 2021, an estimated $170M increase.
- Liontrust Investment Partners's biggest Q4 2021 reduction was Intuit, cutting an estimated $41.2M.
- Liontrust Investment Partners fully exited Moderna in Q4 2021, selling an estimated $19.2M.
- Liontrust Investment Partners's ten largest holdings make up 37% of its $8.41B portfolio in Q4 2021.
- Liontrust Investment Partners opened 22 new positions and closed 43 in Q4 2021.
- Liontrust Investment Partners's portfolio value rose 16% quarter-over-quarter to $8.41B.
Based on Liontrust Investment Partners's 13F filing for Q4 2021, filed 26 Jan 2022.